The Uganda Cancer Institute (UCI) has acquired a Shs15 billion Symbia Intevo Bold Eco SPECT-CT scanner to improve cancer diagnosis and treatment.
The technology enables precise detection of cancer cells, even in challenging areas like bones. Dr. Jackson Orem, UCI's Executive Director, highlighted that this acquisition is part of establishing the Division of Molecular Imaging and Therapy, positioning UCI as a leader in advanced cancer diagnostics in Africa.
Dr. Godfrey Osinde, head of UCI’s Nuclear Medicine department, noted, "This technology allows us to pinpoint cancer cells with remarkable accuracy, paving the way for advanced treatments like Targeted Radionuclide Therapy (TRT)." TRT uses radioactive isotopes to directly attack tumors, minimizing harm to healthy tissue and improving patient outcomes.
The initiative is part of a three-phase project, with Phase I focusing on equipping radiotherapy bunkers and strengthening nuclear medicine capabilities, now 95 percent complete.
Future phases will include an isotope production facility and research facilities, further enhancing UCI's role in cancer treatment and research.
